An overview of IRBM
The IRBM Group is an innovative research and discovery CRO working across all aspects of drug discovery and early development.
Headquartered in Italy, the IRBM Group fosters collaborations with organizations from the pharma, biotech, non-profit and academic sectors to accelerate the development of vaccines and medicines.
About 250 scientists work at IRBM’s R&D facility near Rome, where projects are carried out under one roof, enabling rapid cycle times and close integration of the scientific teams. IRBM’s scientists have discovered several marketed therapeutics, and more than 25 molecules have progressed into clinical testing.
We spoke with IRBM’s Global Vice President of Sales & Marketing, Heidi Kingdon Jones, at Bio-Europe, which was held in Leipzig, Germany.
➡ Subscribe to our newsletter: https://bit.ly/3kHyfKc
➡ Get more biotech news:
Official site: https://bit.ly/3OJgYzi
Linkedin: / 5312453
Twitter: / labiotech_eu
Facebook: / labiotech.eu
Instagram: / labiotech.eu
About Labiotech.eu:
Labiotech.eu is an online publication covering the global biotech industry, with a mix of news and in-depth analysis. Updated daily, the site also includes a weekly podcast.
@irbm_drugdiscovery
#drugdiscovery #biotech #italy #CRO